LONGBIO-B(01779),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01779 LONGBIO-B

Closed 06-25 16:08:06

157.200

+5.500

+3.63%

High160.600	Low151.700	Vol112.70K
Open151.700	D1 Closing151.700	Amplitude5.87%
Mkt Cap11.66B	Tradable Cap11.46B	Total Shares74.19M
T/O17.81M	T/O Rate0.15%	Tradable Shares72.93M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01779","market":"HK","secType":"STK","nameCN":"LONGBIO-B","latestPrice":157.2,"timestamp":1782374886603,"preClose":151.7,"halted":0,"volume":112700,"delay":0,"changeRate":0.03625576796308504,"floatShares":72930300,"shares":74193200,"eps":-2.733,"marketStatus":"Closed","change":5.5,"latestTime":"06-25 16:08:06","open":151.7,"high":160.6,"low":151.7,"amount":17811760,"amplitude":0.058668,"askPrice":158.5,"askSize":50,"bidPrice":157.2,"bidSize":300,"shortable":0,"etf":0,"ttmEps":-2.62,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782437400000},"marketStatusCode":5,"adr":0,"listingDate":1780588800000,"exchange":"SEHK","adjPreClose":151.7,"openAndCloseTimeList":[[1782351000000,1782360000000],[1782363600000,1782374400000]],"volumeRatio":0.405427,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01779/wiki","defaultTab":"wiki","newsList":[{"id":"2642265502","title":"LongBio Pharma (Suzhou) (SEHK:1779) Stock Valuation Looks Stretched After Recent Gain And High P/B Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2642265502","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642265502?lang=en_us&edition=fundamental","pubTime":"2026-06-12 13:25","pubTimestamp":1781241940,"startTime":"0","endTime":"0","summary":"Event overview and immediate market reaction\nLongBio Pharma (Suzhou) (SEHK:1779) moved higher in the latest session, with the stock closing at HK$141.9 after a 3.2% gain for the day, drawing fresh attention from biotech focused investors.\nSee our latest analysis for LongBio Pharma (Suzhou).\nThe 3.2% one day share price return fits into a year to date share price return of 7.66%. This suggests momentum has been gradually building as investors reassess LongBio Pharma (Suzhou)'s risk and growth...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1779/longbio-pharma-suzhou-shares/news/longbio-pharma-suzhou-sehk1779-stock-valuation-looks-stretch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1779/longbio-pharma-suzhou-shares/news/longbio-pharma-suzhou-sehk1779-stock-valuation-looks-stretch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642256141","title":"LongBio Pharma's Seasonal Allergy Drug LP-003 Meets Main Goal of Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2642256141","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642256141?lang=en_us&edition=fundamental","pubTime":"2026-06-12 10:40","pubTimestamp":1781232040,"startTime":"0","endTime":"0","summary":"LongBio Pharma's  seasonal allergic rhinitis treatment LP-003 met the main goal of a phase 3 study, the firm said in a Hong Kong bourse filing Friday.According to LongBio, the late-stage study in China met its pre-specified primary endpoints with \"highly statistically and clinically significant\" results.The firm enrolled 546 patients in the study, including those who did not achieve satisfactory results with standard treatment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118631830","title":"LongBio Pharma’s LP-003 Hits Primary Goals in China Phase III Seasonal Allergic Rhinitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1118631830","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118631830?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:20","pubTimestamp":1781216447,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. reported that its lead candidate LP-003 met all pre-specified primary endpoints in a China-based Phase III clinical trial targeting moderate-to-severe seasonal...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100372939","title":"LONGBIO-B's Phase III Trial for Seasonal Allergic Rhinitis Drug LP-003 Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1100372939","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100372939?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:20","pubTimestamp":1781216427,"startTime":"0","endTime":"0","summary":"LONGBIO-B (HKEX: 01779) has announced that the Phase III clinical trial for LP-003, targeting seasonal allergic rhinitis (hay fever), has successfully achieved its pre-defined primary endpoint. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","01779","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642237367","title":"Longbio Pharma (Suzhou) Co - Phase Iii Trial of Lp-3 for Seasonal Allergic Rhinitis Meets Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2642237367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642237367?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:12","pubTimestamp":1781215949,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0Z4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167380443","title":"LongBio Pharma Announces 2025 AGM; Shareholders to Vote on Profit Distribution, Auditor Re-appointment and Dual Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1167380443","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167380443?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:43","pubTimestamp":1781016201,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. has issued a notice convening its 2025 Annual General Meeting (AGM) for 4:00 p.m. on 30 June 2026 at the company’s headquarters (5th Floor, Building F, Area A, No....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190963931","title":"Can LONGBIO-B Maintain Its Lofty Valuation Ahead of a Potential Stock Connect Inclusion?","url":"https://stock-news.laohu8.com/highlight/detail?id=1190963931","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190963931?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:37","pubTimestamp":1781005044,"startTime":"0","endTime":"0","summary":"The Hang Seng Healthcare Index has been in a downtrend for nearly 40 trading sessions since April 17, with a cumulative decline of approximately 25% as of June 8. The recent string of negative...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165094910","title":"Movement Alert｜Tiachen Bio-B Rises 6.37% in Regular Trading, Sustaining IPO Oversubscription Momentum on Second Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1165094910","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165094910?lang=en_us&edition=fundamental","pubTime":"2026-06-09 09:33","pubTimestamp":1780968836,"startTime":"0","endTime":"0","summary":"On June 9, Tiachen Bio-B rose 6.37% in regular trading, trading at 145.1 HKD/share, with trading volume of 17.38 million HKD. The stock has accumulated a premium of approximately 51% over its IPO...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159755444","title":"Regulator Seeks Clarification from Weizhao Semiconductor on Pricing Disparities Ahead of Planned Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1159755444","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159755444?lang=en_us&edition=fundamental","pubTime":"2026-06-05 22:22","pubTimestamp":1780669361,"startTime":"0","endTime":"0","summary":"On June 5th, China's securities regulator issued a series of requests for supplementary information to companies seeking overseas listings. The international department of the China Securities...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173670917","title":"LONGBIO-B Commences Trading on HKEX with Shares Surging Over 50% at Opening","url":"https://stock-news.laohu8.com/highlight/detail?id=1173670917","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173670917?lang=en_us&edition=fundamental","pubTime":"2026-06-05 20:55","pubTimestamp":1780664142,"startTime":"0","endTime":"0","summary":"On the morning of June 5th, LONGBIO-B (01779.HK) officially commenced trading on the Main Board of the Hong Kong Stock Exchange.On its first day of trading, the stock opened 50.22% higher, reaching...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168170826","title":"IPO Spotlight: Longbio-B Soars on Debut as Investor Demand Soars","url":"https://stock-news.laohu8.com/highlight/detail?id=1168170826","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168170826?lang=en_us&edition=fundamental","pubTime":"2026-06-05 20:31","pubTimestamp":1780662670,"startTime":"0","endTime":"0","summary":"The Hong Kong IPO market has maintained its robust momentum, with several new listings such as Shougang Langze (02553.HK) and Shenyan Intelligent (02723.HK) posting significant surges after their...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144127105","title":"Hong Kong Market Closes Lower, Hang Seng Drops 1.15% Below 25,000; Semiconductors Retreat Sharply; Three New Listings Show Divergent Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1144127105","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144127105?lang=en_us&edition=fundamental","pubTime":"2026-06-05 16:52","pubTimestamp":1780649561,"startTime":"0","endTime":"0","summary":"The Hong Kong stock market opened lower and continued to decline throughout the session, marking a three-day losing streak, with the Hang Seng Index falling below the 25,000-point threshold.At the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCHmain","03115","LU1807302812.USD","SOXL","BK1103","HSImain","83115","SG9999001689.USD","XSD","LU1152091754.HKD","00316","LU1993786604.SGD","03143","LU0211977185.USD","513600","159582","BK1231","BK1610","BK1572","02833","BK4588","02800","CHPS","82800","BK1607","SSG","TEKX","03037","LU1008478684.HKD","07500","BK1163","BK1526","STAN.UK","SMHX","SMH","CHPY","SOXS","HHImain","VXUS","03419","LU0607220059.USD","BK4535","PSI","SG9999000327.SGD","LU0067412154.USD","LU0149534421.HKD","00981","LU1152091168.USD","BK1619","06809","02290","SOXQ","SOXX","BK1601","FTXL","07200","07300","MHImain","BK1614","01779","02888","09115","BK4585","SOXY","USD","LU1960683339.HKD","VGT","HSI","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641341116","title":"Hong Kong Stocks End Week in Red; Three Firms Make Market Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2641341116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641341116?lang=en_us&edition=fundamental","pubTime":"2026-06-05 16:46","pubTimestamp":1780649175,"startTime":"0","endTime":"0","summary":"Hong Kong stocks plunged Friday as tensions in the Middle East showed no signs of letting up and investors booked profits ahead of the weekend.The Hang Seng Index fell by around 291.45 points, or roug","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03115","MCHmain","09115","82800","MHImain","03037","HHImain","07200","02833","83115","HSTECH","01779","02290","02800","HSI","01081","07500","513600","002487","03419","07300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135032397","title":"Stock Track | LONGBIO-B Soars 54.80% Intraday on Blockbuster IPO Debut with Massive Oversubscription","url":"https://stock-news.laohu8.com/highlight/detail?id=1135032397","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135032397?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:35","pubTimestamp":1780623324,"startTime":"0","endTime":"0","summary":"LONGBIO-B's stock soared 54.80% during intraday trading on Friday, marking a dramatic debut on the Hong Kong Stock Exchange.The surge was driven by the company's highly anticipated initial public...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179880168","title":"Movement Alert｜Tianchen Bio-B Rises 51.05% in Regular Trading, Surging on IPO Debut with Over 4762x Oversubscription","url":"https://stock-news.laohu8.com/highlight/detail?id=1179880168","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179880168?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:31","pubTimestamp":1780623086,"startTime":"0","endTime":"0","summary":"On June 5, Tianchen Bio-B rose 51.05% in regular trading on its first day of listing, trading at 146.7 HKD/share, with trading volume of approximately 306 million HKD, significantly above the IPO...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120471763","title":"New Listing Debut | LONGBIO-B (01779) Starts Trading with 50.22% Premium, Core Product LP-003 in Eight Chinese Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1120471763","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120471763?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:30","pubTimestamp":1780623029,"startTime":"0","endTime":"0","summary":"LONGBIO-B (01779) commenced trading today, following its initial public offering where shares were priced at HK$96.06 each.The company issued a total of 14.1932 million shares in lots of 50, raising...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641616013","title":"LongBio Pharma Raises HK$1.3 Billion in Hong Kong IPO Ahead of Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2641616013","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641616013?lang=en_us&edition=fundamental","pubTime":"2026-06-05 06:01","pubTimestamp":1780610501,"startTime":"0","endTime":"0","summary":"LongBio Pharma (HKG:1779) raised HK$1.25 billion in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$96.06 per H-share, according to a Thursday after-mark","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01779","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163073322","title":"Longbio-B IPO Sees Massive Oversubscription, Raises Approximately HK$1.255 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1163073322","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163073322?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:34","pubTimestamp":1780583676,"startTime":"0","endTime":"0","summary":"Longbio-B (HKEX: 01779) has announced the allocation results for its initial public offering. The global offering comprised 14,193,150 shares, with the Hong Kong public offering portion accounting...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164521046","title":"New Stock Pre-Market Surge: LONGBIO-B (01779) Soars Over 135%, Generating HK$6,487 Per Board Lot","url":"https://stock-news.laohu8.com/highlight/detail?id=1164521046","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164521046?lang=en_us&edition=fundamental","pubTime":"2026-06-04 16:30","pubTimestamp":1780561836,"startTime":"0","endTime":"0","summary":"Shares of LONGBIO-B (01779), which is scheduled to commence trading on the Hong Kong Stock Exchange this Friday, June 5th, have surged dramatically in pre-market dealings.As of the latest update, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194310890","title":"HK Grey Market | LongBio Jumps 138%; Lung Fung Jumps 22%; Dajin Heavy Drops 5%;","url":"https://stock-news.laohu8.com/highlight/detail?id=1194310890","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194310890?lang=en_us&edition=fundamental","pubTime":"2026-06-04 16:18","pubTimestamp":1780561092,"startTime":"0","endTime":"0","summary":"$LONGBIO-B(01779)$ jumped 138% in Hong Kong’s grey market trading. LONGBIO-B is a clinical-stage biopharmaceutical company headquartered in Shanghai and Changshu (Suzhou), China. Founded in 2020, it...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","01081","02290"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.longbio.com","stockEarnings":[{"period":"1week","weight":0.0836},{"period":"1month","weight":0.5792},{"period":"ytd","weight":0.5792}],"compareEarnings":[{"period":"1week","weight":-0.037},{"period":"1month","weight":-0.0857},{"period":"3month","weight":-0.0581},{"period":"6month","weight":-0.0932},{"period":"1year","weight":-0.0316},{"period":"ytd","weight":-0.0866}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"LongBio Pharma (Suzhou) Co Ltd is a China-based company primarily engaged in the in-house discovery and development of biopharmaceuticals targeting allergic and autoimmune diseases. The Company's main products include LP-003 and LP-005. LP-003 is targeted to treat allergic diseases, including seasonal AR, CSU, allergic asthma, food allergy and other allergic diseases. LP-005 is used for paroxysmal nocturnal hemoglobinuria (PNH), complement-mediated kidney diseases, which includes IgA nephropathy (IgAN), C3 glomerulopathy (C3G) and lupus nephritis (LN) and other complement related indications. The Company mainly operates its businesses in the domestic market.","exchange":"SEHK","name":"LONGBIO-B","nameEN":"LONGBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LONGBIO-B(01779),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LONGBIO-B(01779) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LONGBIO-B,01779,LONGBIO-B股票,LONGBIO-B股票老虎,LONGBIO-B股票老虎国际,LONGBIO-B行情,LONGBIO-B股票行情,LONGBIO-B股价,LONGBIO-B股市,LONGBIO-B股票价格,LONGBIO-B股票交易,LONGBIO-B股票购买,LONGBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LONGBIO-B(01779),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LONGBIO-B(01779) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}